Zimmer Biomet Holdings Inc (NYSE:ZBH) Shorted Shares Increased By 4.87%

June 29, 2018 - By Jeanette Garcia

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Corporate Logo

Zimmer Biomet Holdings Inc (NYSE:ZBH) had an increase of its short interest by 4.87%. FINRA announced in June ZBH’s total 3.56M short interest. That’s 4.87% up from 3.40M shares. Zimmer Biomet Holdings Inc (NYSE:ZBH) has 1.58M shares average volume. It’ll cost 2 days for ZBH to restore its former position. Float short on Zimmer Biomet Holdings Inc is 1.76%.

The stock increased 1.48% or $1.65 during the last trading session, touching $112.92.Zimmer Biomet Holdings, Inc. has volume of 268,906 shares. Since June 29, 2017 ZBH has declined 6.89% and is downtrending. ZBH underperformed by 19.46% the S&P 500.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, makes, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.The company has $22.95 billion market cap. It operates through four divisions: Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic , and Dental.13.65 is the P/E ratio. The firm provides orthopedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Ratings Coverage

In total 17 analysts cover Zimmer Biomet Holdings (NYSE:ZBH). “Buy” rating has 11, “Sell” are 1, while 5 are “Hold”. (NYSE:ZBH) has 65% bullish analysts. 22 are the (NYSE:ZBH)’s ratings reports on Jun 29, 2018 according to StockzIntelligence Inc. On Wednesday, January 31 the stock of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) earned “Outperform” rating by Leerink Swann. In Friday, June 22 report Argus Research downgraded the stock to “Hold” rating. In Friday, April 27 report Morgan Stanley maintained the stock with “Overweight” rating. On Thursday, January 4 Canaccord Genuity maintained Zimmer Biomet Holdings, Inc. (NYSE:ZBH) with “Hold” rating. On Monday, February 26 Morgan Stanley maintained Zimmer Biomet Holdings, Inc. (NYSE:ZBH) rating. Morgan Stanley has “Overweight” rating and $148 target. On Friday, January 26 the stock of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has “Buy” rating given by SunTrust. On Friday, April 27 Needham maintained Zimmer Biomet Holdings, Inc. (NYSE:ZBH) with “Buy” rating. On Tuesday, January 30 the stock of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) earned “Buy” rating by BMO Capital Markets. On Wednesday, January 31 the firm has “Buy” rating given by Guggenheim. On Friday, March 23 the stock of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has “Neutral” rating given by Robert W. Baird.

A couple more Zimmer Biomet Holdings, Inc. (NYSE:ZBH) news were published by: Seekingalpha.com which released on June 27, 2018 “Medical device makers ISRG, BSX, ABT started with bullish view at Bernstein”, also Benzinga.com on June 22, 2018 published “Argus Drops Bullish Zimmer Biomet Thesis On Manufacturing, Supply, Sales Worries”, the next Benzinga.com is “Benzinga’s Bulls & Bears Of The Week: AMD, Disney, Nike, Tesla And More” on June 24, 2018. Benzinga.com has article titled “Benzinga’s Top Upgrades, Downgrades For June 22, 2018”.

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.